These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37511794)

  • 1. Influence of the Bile Acid Transporter Genes
    Kreimeyer H; Vogt K; Götze T; Best J; Götze O; Weigt J; Kahraman A; Özçürümez M; Kälsch J; Syn WK; Sydor S; Canbay A; Manka P
    J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Castelnuovo G; Perez-Diaz-Del-Campo N; Rosso C; Guariglia M; Armandi A; Nicolosi A; Caviglia GP; Bugianesi E
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in Liver Fibrosis Associates with Progress of Diabetic Nephropathy in Patients with Nonalcoholic Fatty Liver Disease.
    Terasaka Y; Takahashi H; Amano K; Fujisaki K; Kita S; Kato K; Nakayama K; Yamashita Y; Nakamura S; Anzai K
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.
    Song BG; Choi SC; Goh MJ; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Paik SW
    JHEP Rep; 2023 Sep; 5(9):100810. PubMed ID: 37538246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of multi-echo Dixon and MRS in quantifying hepatic fat content and staging liver fibrosis.
    Jiang Y; Zou J; Fan F; Yang P; Ma L; Gan T; Wang S; Zhang J
    Sci Rep; 2023 Aug; 13(1):12555. PubMed ID: 37532757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
    Li R; Li M; Bidulescu A; Fly AD; Luo J
    Dig Dis Sci; 2023 Oct; 68(10):4009-4021. PubMed ID: 37535123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora.
    Miao X; Luo P; Liu J; Wang J; Chen Y
    Lipids Health Dis; 2023 Aug; 22(1):112. PubMed ID: 37533083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients.
    Pérez-Rubio Á; Soluyanova P; Moro E; Quintás G; Rienda I; Periañez MD; Painel A; Vizuete J; Pérez-Rojas J; Castell JV; Trullenque-Juan R; Pareja E; Jover R
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of extracellular vesicles in nonalcoholic fatty liver disease.
    Jiang W; Xu Y; Chen JC; Lee YH; Hu Y; Liu CH; Chen E; Tang H; Zhang H; Wu D
    Front Endocrinol (Lausanne); 2023; 14():1196831. PubMed ID: 37534206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players.
    Rodríguez-Lara A; Rueda-Robles A; Sáez-Lara MJ; Plaza-Diaz J; Álvarez-Mercado AI
    Pathogens; 2023 Jul; 12(7):. PubMed ID: 37513787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
    Lee HA; Moon H; Kim Y; Lee HA; Kim HY
    Trials; 2023 Aug; 24(1):490. PubMed ID: 37533096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice.
    Yao Z; Guo J; Du B; Hong L; Zhu Y; Feng X; Hou Y; Shi A
    Front Microbiol; 2023; 14():1147067. PubMed ID: 37538846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells.
    Yi Q; Yang J; Wu Y; Wang Y; Cao Q; Wen W
    Front Immunol; 2023; 14():1204524. PubMed ID: 37539053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy.
    Amatya R; Lee D; Min KA; Shin MC
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty Liver Index and Its Association with 10-Year Atherosclerotic Cardiovascular Disease Risk: Insights from a Population-Based Cross-Sectional Study in China.
    Zhou J; Fan J; Zhang X; You L; Lin D; Huang C; Li F; Sun K
    Metabolites; 2023 Jul; 13(7):. PubMed ID: 37512557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.
    Sanyal AJ; Ratziu V; Loomba R; Anstee QM; Kowdley KV; Rinella ME; Sheikh MY; Trotter JF; Knapple W; Lawitz EJ; Abdelmalek MF; Newsome PN; Boursier J; Mathurin P; Dufour JF; Berrey MM; Shiff SJ; Sawhney S; Capozza T; Leyva R; Harrison SA; Younossi ZM
    J Hepatol; 2023 Nov; 79(5):1110-1120. PubMed ID: 37517454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Potential Performance of Fibroscan for Predicting and Evaluating Metabolic Syndrome using a Feature Selected Strategy of Machine Learning.
    Chiu KL; Chen YD; Wang ST; Chang TH; Wu JL; Shih CM; Yu CS
    Metabolites; 2023 Jul; 13(7):. PubMed ID: 37512529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Obesity: Complications and Current Day Management.
    Vajravelu ME; Tas E; Arslanian S
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 intake is associated with liver disease protection.
    Vell MS; Creasy KT; Scorletti E; Seeling KS; Hehl L; Rendel MD; Schneider KM; Schneider CV
    Front Public Health; 2023; 11():1192099. PubMed ID: 37538264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
    Nunes BCM; de Moura DTH; Kum AST; de Oliveira GHP; Hirsch BS; Ribeiro IB; Gomes ILC; de Oliveira CPM; Mahmood S; Bernardo WM; de Moura EGH
    Obes Surg; 2023 Sep; 33(9):2917-2926. PubMed ID: 37537506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.